Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
- PMID: 26908686
- DOI: 10.1542/peds.2015-4467
Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
Abstract
Description: This article describes the update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents.
Methods: The USPSTF reviewed the evidence on the benefits and harms of screening, accuracy of primary care-feasible screening tests, and benefits and harms of treatment with psychotherapy, medications, and collaborative care models in patients aged 7 to 18 years.
Population: This recommendation applies to children and adolescents aged ≤18 years who do not have an MDD diagnosis.
Recommendation: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up (B recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged ≤11 years (I statement).
Copyright © 2016 by the American Academy of Pediatrics.
Similar articles
-
Screening for Depression in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement.Ann Intern Med. 2016 Mar 1;164(5):360-6. doi: 10.7326/M15-2957. Epub 2016 Feb 9. Ann Intern Med. 2016. PMID: 26858097
-
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2016 Jan 26;315(4):380-7. doi: 10.1001/jama.2015.18392. JAMA. 2016. PMID: 26813211
-
Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.Pediatrics. 2013 Nov;132(5):907-14. doi: 10.1542/peds.2013-2864. Epub 2013 Oct 7. Pediatrics. 2013. PMID: 24101758 Review.
-
Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Oct 18;328(15):1534-1542. doi: 10.1001/jama.2022.16946. JAMA. 2022. PMID: 36219440
-
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044. JAMA. 2022. PMID: 35997723 Review.
Cited by
-
The effectiveness of collaborative care delivered via telehealth in a pediatric primary care population.Front Psychiatry. 2023 Nov 13;14:1240902. doi: 10.3389/fpsyt.2023.1240902. eCollection 2023. Front Psychiatry. 2023. PMID: 38025414 Free PMC article.
-
Diagnostic et traitement de la dépression à l’adolescence.CMAJ. 2023 Aug 14;195(31):E1050-E1058. doi: 10.1503/cmaj.220966-f. CMAJ. 2023. PMID: 37580075 Free PMC article. Review. French. No abstract available.
-
Evaluating the Psychometric Properties and Clinical Utility of a Digital Psychosocial Self-Screening Tool (HEARTSMAP-U) for Postsecondary Students: Prospective Cohort Study.JMIR Ment Health. 2023 Aug 9;10:e48709. doi: 10.2196/48709. JMIR Ment Health. 2023. PMID: 37556180 Free PMC article.
-
Can the Center for Epidemiologic Studies Depression Scale Be Used to Screen for Depression in Children and Adolescents? An Updated Systematic Review.Child Psychiatry Hum Dev. 2023 Jun 24. doi: 10.1007/s10578-023-01553-6. Online ahead of print. Child Psychiatry Hum Dev. 2023. PMID: 37354303
-
Diagnosis and management of depression in adolescents.CMAJ. 2023 May 29;195(21):E739-E746. doi: 10.1503/cmaj.220966. CMAJ. 2023. PMID: 37247881 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
